Literature DB >> 8405048

Interferon-gamma regulation of C4 gene expression in cultured human glomerular epithelial cells.

W Zhou1, R D Campbell, J Martin, S H Sacks.   

Abstract

The fourth component of human complement is mainly produced in liver, but extrahepatic gene expression has been reported in human renal tissue and other tissues, and is thought to contribute to the inflammatory reaction in local tissue. To identify the cellular origin of C4 synthesis in human kidney, we studied C4 gene expression and regulation by interferon-gamma (IFN-gamma) and C4 protein biosynthesis in isolated glomerular epithelial cells. cDNA/polymerase chain reaction analysis showed that C4 transcripts are present in glomerular epithelial cells (GEC), and that gene expression is up-regulated by IFN-gamma. Metabolic labeling studies showed that GEC synthesize and secrete C4 as three polypeptide chains of approximately 90, 70, and 30 kDa, which correspond to the bands produced by hepatoma cells. These results suggest that the fourth component of complement is produced by GEC. The GEC has an important role in the maintenance of glomerular barrier function, which is lost in a number of complement-dependent conditions; glomerular epithelial synthesis of C4 could have a bearing on the possible physiological or pathological roles of complement under different circumstances.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405048     DOI: 10.1002/eji.1830231015

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  In situ localization of C3 synthesis in experimental acute renal allograft rejection.

Authors:  J R Pratt; K Abe; M Miyazaki; W Zhou; S H Sacks
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 2.  The effect of locally synthesised complement on acute renal allograft rejection.

Authors:  Steven Sacks; Wuding Zhou
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

Review 3.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

4.  Altered distribution of intraglomerular immune complexes in C3-deficient mice.

Authors:  N S Sheerin; T Springall; M Carroll; S H Sacks
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

Review 5.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

Review 6.  Post-bone marrow transplant thrombotic microangiopathy.

Authors:  F Obut; V Kasinath; R Abdi
Journal:  Bone Marrow Transplant       Date:  2016-03-14       Impact factor: 5.483

7.  Expression of complement components, receptors and regulators by human dendritic cells.

Authors:  Ke Li; Henrieta Fazekasova; Naiyin Wang; Pervinder Sagoo; Qi Peng; Wafa Khamri; Chantelle Gomes; Steven H Sacks; Giovanna Lombardi; Wuding Zhou
Journal:  Mol Immunol       Date:  2011-03-23       Impact factor: 4.407

8.  Which pathways trigger the role of complement in ischaemia/reperfusion injury?

Authors:  Conrad A Farrar; Elham Asgari; Wilhelm J Schwaeble; Steven H Sacks
Journal:  Front Immunol       Date:  2012-11-19       Impact factor: 7.561

Review 9.  Overview of complement activation and regulation.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

10.  The Expression Profile of Complement Components in Podocytes.

Authors:  Xuejuan Li; Fangrui Ding; Xiaoyan Zhang; Baihong Li; Jie Ding
Journal:  Int J Mol Sci       Date:  2016-03-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.